MYCN is known to be a strong dependency factor in neuroblastomas with amplified MYCN (19, 33), accounting for the fact that neuroblastoma cells either undergo apoptosis or stop proliferating and undergo changes in gene expression consistent with terminal differentiation whenever the adrenergic CRC is dismantled and MYCN levels fall. Here, MYCN is linked to neuroblastoma.